Researchers at the University of Michigan found that psilocybin significantly reduced chronic touch-related pain in rats without affecting heat-related pain. The pain relief outlasted the drug's presence in the body, suggesting a central brain mechanism could be responsible.
A recent study found no link between trauma history and the severity of psychedelic challenges or subsequent psychological growth, suggesting individual reactions to ayahuasca are highly variable.
Psychedelics like LSD and magic mushrooms could significantly enhance sexual well-being, offering promising alternatives to conventional treatments for sexual dysfunction, especially in those suffering from depression.
Researchers have discovered that ayahuasca, particularly due to its component harmine, acts as a powerful analgesic in mice without causing any detectable toxic effects.
A global survey found that 70.9% of participants reported reducing or ceasing their use of non-psychedelic substances like alcohol and tobacco after using psychedelics, with psilocybin being the most influential.
Participants in an ayahuasca retreat reported a significant, sustained increase in aesthetic appreciation one week and one month post-consumption.
Researchers recently explored the potential of psilocybin, a compound from magic mushrooms, to combat diabetes. The findings suggest that psilocybin might protect pancreatic β-cells from damage.
LSD increases neural complexity and reduces certain brain wave frequencies, which correlates with feelings of elation, according to new research.
A pivotal study explored how patient expectations affect psilocybin therapy outcomes, discovering no significant impact. Interestingly, suggestible individuals showed enhanced benefits, suggesting a unique interplay between mindset and psychedelic therapy effectiveness.
A new study provides evidence that mushroom extract containing psilocybin may offer superior therapeutic effects for psychiatric disorders compared to synthetic psilocybin, suggesting an "entourage effect" of additional compounds enhancing treatment outcomes.
Psilocybin therapy alters brain activity in patients with alcohol use disorder, according to new research, increasing activity in areas associated with emotional regulation and reducing activity in regions linked to craving.
A groundbreaking study sheds light on psilocybin therapy's success in treating depression, highlighting the crucial roles of mystical experiences and ego dissolution, enhanced by music, in surpassing traditional treatments. The findings were published in the International Journal of Mental Health...
A JAMA Psychiatry study explores the link between psychedelic use in adolescents and mental health, finding an association with fewer psychotic symptoms and a correlation with increased manic symptoms in those with genetic risks for schizophrenia or bipolar disorder.
Ayahuasca was found to speed up the extinction of fear memories in rats by affecting serotonin receptors in the brain. This effect, consistent across new and old memories, points to potential therapeutic uses for anxiety and trauma-related conditions.
A study revealed psilocybin diminishes the amygdala response to angry faces, potentially impacting emotion processing. This discovery underscores its potential for treating conditions like depression and anxiety, highlighting the profound effects of psychedelics on the brain.